Why it was recalled
Lack of sterility assurance.
Product description
Prostaglandin Tri-Mix 60:30:1 Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
Lot numbers, UPCs & expiration codes
All Lots
Where it was sold
Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-1186-2019
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Apr 2, 2019
- FDA report date
- Apr 24, 2019
- Quantity
- N/A
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy
Original FDA data
Every field from FDA enforcement report D-1186-2019, exactly as published.
Show all FDA fields
- City
- Bristol
- State
- TN
- Status
- Terminated
- Country
- United States
- Event ID
- 82554
- Address
- Attn: Cleve Anderson
- Address (line 2)
- 310 Bluff City Hwy
- Code information
- All Lots
- Postal code
- 37620-4602
- Report date
- Apr 24, 2019
- Product type
- Drugs
- Recall number
- D-1186-2019
- Classification
- Class II
- Recalling firm
- Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy
- Termination date
- Sep 24, 2021
- Reason for recall
- Lack of sterility assurance.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Prostaglandin Tri-Mix 60:30:1 Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
- Distribution pattern
- Nationwide
- Recall initiation date
- Apr 2, 2019
- Initial firm notification
- Letter
- Center classification date
- Apr 18, 2019